Evidence map›Paper›PMID 32637353›Full record

ArticleFrontiers in oncology2020

Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer.

Huan Wang, Yongfeng Ding, Ning Li, Luntao Wu, Yuan Gao, Cheng Xiao, Haiping Jiang, Yulong Zheng, Chenyu Mao, Jing Deng and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Huan WangDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Yongfeng DingDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Ning LiDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Luntao WuDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Yuan GaoDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Cheng XiaoDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Haiping JiangDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Yulong ZhengDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Chenyu MaoDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Jing DengDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Haiyong WangDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Nong XuDepartment of Medical Oncology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gastric cancerneutrophil–lymphocyte ratioplatelet–lymphocyte ratioprognosisstage IV

Identifiers

PMID32637353
PMCPMC7317009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.